REGN

Regeneron Pharmaceuticals Inc
Data: 2026-08-21
$834.04
Price
0.90%
Change
$847.00
52W High
$541.00
52W Low

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).

Quick Stats
Aug 21, 2026

33.5

AI Score

EXTENDED

1.07

Volume Ratio

TBA

Next Earnings

21

+ve Days (30d)

9

-ve Days (30d)

REGN Stock Summary

Last updated Aug 21, 2026

REGN is currently trading at $834.04, positioned above its 200-day moving average of $724.55, indicating a long-term uptrend. The stock has a 52-week range of $541 to $847.

Technical Analysis: The 50-day moving average stands at $696.27, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 76.045, suggesting the stock is in overbought territory (bullish but caution advised).

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.244, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates REGN at 33.5/100 with a EXTENDED recommendation.

REGN (Regeneron Pharmaceuticals Inc) Indicators

Last updated Aug 21, 2026

Indicator Value
RSI(14) 76.045
CMF (20) 0.244
ROC (10) 6.334
ADX (14) 49.526
Indicator Value
MACD (12,26,9) 39.652
AROONOSC (14) 92.857
WILLAMS %R (14) -12.96
MFI (14) 74.383
REGN Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

REGN Price vs Max Options Open Interest
REGN Max Change In Options Open Interest

REGN Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

REGN Daily Out of Money Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

REGN Daily In the Money Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

REGN Most Active Options by Volume(near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Regeneron Pharmaceuticals Inc is above both the 50 Day and 200 Day SMA which is considered Bullish.

REGN Moving Averages Analysis

Regeneron Pharmaceuticals Inc has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Aug 21, 2026

Regeneron Pharmaceuticals Inc has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Aug 21, 2026

REGN (Regeneron Pharmaceuticals Inc) Simple Moving Averages

Moving Averages are last updated Aug 21, 2026

Days MA
10 813.02
20 776.69
30 739.32
50 696.27
100 697.55
200 724.55

REGN Fundamental Analysis

P/E (Forward) 17.6367
P/E (Trailing) 19.7229
Market Cap ($) 82.2 billion
Earnings/Share ($) 40.46
Net Profit Margin (%) 0.2787
Dividend/Share ($) 3.64
EPS Estimate Current Year ($) 53.005
EPS Estimate Next Year ($) 50.4007
WallStreet Target Price ($) 833.54
Most Recent Quarter